Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1 Meeting Abstract
| Authors: | Danilov, A.; Fakhri, B.; Awan, F. T.; Bentzen, H. H.; Eradat, H. A.; Niemann, C. U.; Offner, F.; Poulsen, C. B.; Hoeyer, T.; Bellido, M.; Weil, D. R.; Ferrajoli, A.; Thompson, M. C.; Christensen, J. H.; Janssens, A.; Tadmor, T.; Shadman, M.; Jafarinasabian, P.; Zhang, J. M.; Rios, M.; Kuznetsova, A.; Valentin, R.; Kater, A. P. |
| Abstract Title: | Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1 |
| Meeting Title: | Blood |
| Journal Title: | Blood |
| Volume: | 144 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-01 |
| Start Page: | 883 |
| End Page: | 885 |
| Language: | English |
| ACCESSION: | WOS:001412804100027 |
| DOI: | 10.1182/blood-2024-199708 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- 66th Annual Meeting of the American-Society-of-Hematology (ASH) -- DEC 06-09, 2025 -- 1 -- Orlando, FL -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work